Allergy/Immunology Research Center of north Texas

Dallas, Texas 75230

0 studies enrolling now · 7 studies all time

What they study most

Acute, Uncomplicated Human Influenza, Asthma, Influenza, Influenza Vaccine, Nasal Congestion, Primary Immune Deficiency Disorders (PIDD), Primary Immunodeficiency Diseases (PID)

Studies at this site

• Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) — Completed
• A Phase 2 Study to Evaluate Immune Responses of FluMist® — Completed
• Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) — Completed
• Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza — Stopped early
• A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza — Completed
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma — Completed
• To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses — Completed